Levaquin and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Levaquin (levofloxacin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Pain.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Levaquin. It is created by eHealthMe based on reports of 54,998 people who have side effects when taking Levaquin from the FDA, and is updated regularly.
What is Levaquin?
Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,509 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
54,998 people reported to have side effects when taking Levaquin.
Among them, 321 people (0.58%) have Malignant neoplasm progression.

Among these 321 people:
How long have people been on Levaquin when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Levaquin? *
What is the age of people who have Malignant neoplasm progression when taking Levaquin? *
What are other drugs people take besides Levaquin? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Levaquin and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Levaquin:
- Levaquin (56,638 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of levofloxacin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levaquin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,509 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,636 conditions)
Related publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levofloxacin (the active ingredients of Levaquin) and Levaquin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Duoneb and Celebrex - now
- Catatonia and drugs of ingredients of ribavirin - 7 seconds ago
- Wellbutrin and Combivent drug interactions for women aged 30-39 - 7 seconds ago
- Drug interactions of Cephalexin and Pifeltro - 15 seconds ago
- Could Propranolol Hydrochloride cause Tooth Abscess? - 19 seconds ago
- Aggression and drugs of ingredients of amisulpride - 24 seconds ago
- Plavix and Lipitor drug interactions for women aged 50-59 - 46 seconds ago
- Fatigue in Anusol Hc, how severe and when it was recovered? - 53 seconds ago
- Could Azelastine Hydrochloride cause Sleep Apnea Syndrome? - 54 seconds ago
- Migraine and drugs of ingredients of simvastatin - a minute ago